External counterpulsation systems developer Vasomedical introduced its Electronic Communication Module for the EECP Therapy System. The FDA-cleared EECP external counterpulsation therapy is a non-invasive therapeutic option for angina and heart-failure patients, according to the company. The module uses Bluetooth technology to wirelessly transmit encrypted patient data from the system to a PC.